{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:58:37Z","timestamp":1785207517512,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acromegaly is a disease of growth hormone excess that results in enlargement of extremities, abnormal glucose and lipid metabolism, and gonadal disruption. Manifestations of the disease are insidious and typically lead to a diagnostic delay of 7\u201310\u2009years. Classically the polycystic ovary syndrome (PCOS) phenotype is described in women with irregular menses, clinical\u00a0or biochemical evidence of androgen excess, and\/or multiple ovarian follicles on pelvic ultrasonography. Women with acromegaly may present with some or all of these symptoms. Our objective was to evaluate the prevalence of PCOS in patients with acromegaly and to determine if diagnosis of PCOS results in a delay in diagnosing acromegaly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using patient databases at two academic health centers, we identified 97 premenopausal women aged 18\u201349\u2009years old presenting with acromegaly. Data were collected regarding pelvic sonography and reproductive history, including the diagnosis of   PCOS. Patients carrying the diagnosis of PCOS before their diagnosis of acromegaly were identified and the remaining patients were screened using the Rotterdam criteria to identify additional patients meeting the  criteria for PCOS prior to their diagnosis of acromegaly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Mean age of the population (<jats:italic>n<\/jats:italic>\u2009=\u200997) at the time of diagnosis of acromegaly was 33.4\u2009\u00b1\u20097.5\u2009years (SD). Thirty-three percent of patients (<jats:italic>n<\/jats:italic>\u2009=\u200932) either carried a diagnosis of PCOS or met diagnostic criteria for PCOS before their diagnosis of acromegaly. In the subset of patients in whom data on symptom onset were available, those who met criteria for PCOS were diagnosed with acromegaly a median of 5\u2009years [4, 9] after the onset of symptoms compared to 2\u2009years [0.92, 3] (<jats:italic>p<\/jats:italic>\u2009=\u2009\u20090.006) in the patients who did not meet criteria for PCOS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data demonstrate a high prevalence of signs and symptoms of PCOS in reproductive-aged women with acromegaly and a longer time to diagnosis in women who meet the clinical criteria for PCOS. As screening for acromegaly is relatively simple and done with measurement of a random, non-fasting IGF-1 level that can be drawn at any time during the menstrual cycle, screening patients with PCOS for acromegaly may lessen the delay in diagnosis for reproductive-aged women with this disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-023-01057-x","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T05:08:54Z","timestamp":1675228134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Polycystic ovary syndrome preceding the diagnosis of acromegaly: a retrospective study in 97 reproductive-aged women"],"prefix":"10.1186","volume":"21","author":[{"given":"Anamil M.","family":"Khiyami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh Orouji","family":"Jokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein M.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios A.","family":"Zenonos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron K.","family":"Styer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1731-2927","authenticated-orcid":false,"given":"Pouneh K.","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"1057_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","volume":"20","author":"A Lavrentaki","year":"2017","unstructured":"Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N. Epidemiology of acromegaly: review of population studies. Pituitary. 2017;20:4\u20139.","journal-title":"Pituitary"},{"key":"1057_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11102-006-0409-4","volume":"9","author":"M Scacchi","year":"2006","unstructured":"Scacchi M, Cavagnini F. Acromegaly. Pituitary. 2006;9:297\u2013303.","journal-title":"Pituitary"},{"key":"1057_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11102-016-0772-8","volume":"20","author":"L Vilar","year":"2017","unstructured":"Vilar L, Vilar CF, Lyra R, Naves LA. Acromegaly: clinical features at diagnosis. Pituitary. 2017;20:22\u201332.","journal-title":"Pituitary"},{"key":"1057_CR4","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1210\/jc.2009-2815","volume":"95","author":"M Grynberg","year":"2010","unstructured":"Grynberg M, Salenave S, Young J, Chanson P. Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab. 2010;95:4518\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"1057_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Group REA-SPCW","year":"2004","unstructured":"Group REA-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u201325.","journal-title":"Fertil Steril"},{"key":"1057_CR6","first-page":"149","volume":"59","author":"S Hashimoto","year":"2003","unstructured":"Hashimoto S, Yatabe J, Midorikawa S, Sanada H, Watanabe T. Inhibition of growth hormone excess reduces insulin resistance and ovarian dysfunction in a lean case of polycystic ovary syndrome with a growth-hormone-producing pituitary adenoma. Horm Res. 2003;59:149\u201355.","journal-title":"Horm Res"},{"key":"1057_CR7","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355:2558\u201373.","journal-title":"N Engl J Med"},{"key":"1057_CR8","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:3933\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"1057_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11102-016-0725-2","volume":"19","author":"A Abreu","year":"2016","unstructured":"Abreu A, Tovar AP, Castellanos R, Valenzuela A, Giraldo CM, Pinedo AC, et al. Challenges in the diagnosis and management of acromegaly: a focus on comorbidities. Pituitary. 2016;19:448\u201357.","journal-title":"Pituitary"},{"key":"1057_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1046\/j.1365-2265.2001.01214.x","volume":"54","author":"L Katznelson","year":"2001","unstructured":"Katznelson L, Kleinberg D, Vance ML, Stavrou S, Pulaski KJ, Schoenfeld DA, et al. Hypogonadism in patients with acromegaly: data from the multi-Centre acromegaly registry pilot study. Clin Endocrinol. 2001;54:183\u20138.","journal-title":"Clin Endocrinol"},{"key":"1057_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1507\/endocrj.40.207","volume":"40","author":"A Unal","year":"1993","unstructured":"Unal A, Sahin Y, Kele\u015ftimur F. Acromegaly with polycystic ovaries, hyperandrogenism, hirsutism, insulin resistance and acanthosis nigricans: a case report. Endocr J. 1993;40:207\u201311.","journal-title":"Endocr J"},{"key":"1057_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1210\/jcem-72-1-83","volume":"72","author":"JE Nestler","year":"1991","unstructured":"Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72:83\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1057_CR13","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metab. 2021;106:e1071\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"1057_CR14","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1210\/jcem-71-4-958","volume":"71","author":"RR Kazer","year":"1990","unstructured":"Kazer RR, Unterman TG, Glick RP. An abnormality of the growth hormone\/insulin-like growth factor-I axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1990;71:958\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"1057_CR15","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/oxfordjournals.humrep.a137577","volume":"7","author":"R Homburg","year":"1992","unstructured":"Homburg R, Pariente C, Lunenfeld B, Jacobs HS. The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Hum Reprod. 1992;7:1379\u201383.","journal-title":"Hum Reprod"},{"key":"1057_CR16","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0015-0282(16)57475-5","volume":"63","author":"RS Morris","year":"1995","unstructured":"Morris RS, Carmina E, Vijod MA, Stanczyk FZ, Lobo RA. Alterations in the sensitivity of serum insulin-like growth factor 1 and insulin-like growth factor binding protein-3 to octreotide in polycystic ovary syndrome. Fertil Steril. 1995;63:742\u20136.","journal-title":"Fertil Steril"},{"key":"1057_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1507\/endocrj.K08E-215","volume":"56","author":"J Goto","year":"2009","unstructured":"Goto J, Otsuka F, Inagaki K, Tsukamoto N, Suzuki J, Miyoshi T, et al. Effects of growth hormone reduction in a patient with polycystic ovary syndrome complicated with acromegaly. Endocr J. 2009;56:157\u201360.","journal-title":"Endocr J"},{"key":"1057_CR18","doi-asserted-by":"crossref","unstructured":"Abdo S, Samaras K. Hair, sweat and tears. BMJ Case Rep. 2011;2011:bcr0520114177.","DOI":"10.1136\/bcr.05.2011.4177"},{"key":"1057_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2169\/internalmedicine.35.803","volume":"35","author":"M Hara","year":"1996","unstructured":"Hara M, Ichikawa K, Minemura K, Kobayashi H, Suzuki N, Sakurai A, et al. Acromegaly associated with Chiari-I malformation and polycystic ovary syndrome. Intern Med. 1996;35:803\u20137.","journal-title":"Intern Med"},{"key":"1057_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12020-018-1540-5","volume":"60","author":"SC Dogansen","year":"2018","unstructured":"Dogansen SC, Tanrikulu S, Yalin GY, Yarman S. Female gonadal functions and ovarian reserve in patients with acromegaly: experience from a single tertiary center. Endocrine. 2018;60:167\u201374.","journal-title":"Endocrine"},{"key":"1057_CR21","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1365-2265.2007.02987.x","volume":"67","author":"GA Kaltsas","year":"2007","unstructured":"Kaltsas GA, Androulakis II, Tziveriotis K, Papadogias D, Tsikini A, Makras P, et al. Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clin Endocrinol. 2007;67:917\u201322.","journal-title":"Clin Endocrinol"},{"key":"1057_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41574-019-0280-9","volume":"16","author":"JJ Kopchick","year":"2020","unstructured":"Kopchick JJ, Berryman DE, Puri V, Lee KY, Jorgensen JOL. The effects of growth hormone on adipose tissue: old observations, new mechanisms. Nat Rev Endocrinol. 2020;16:135\u201346.","journal-title":"Nat Rev Endocrinol"},{"key":"1057_CR23","doi-asserted-by":"publisher","first-page":"111038","DOI":"10.1016\/j.mce.2020.111038","volume":"518","author":"R Sharma","year":"2020","unstructured":"Sharma R, Kopchick JJ, Puri V, Sharma VM. Effect of growth hormone on insulin signaling. Mol Cell Endocrinol. 2020;518:111038.","journal-title":"Mol Cell Endocrinol"},{"key":"1057_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1210\/jc.2005-1804","volume":"91","author":"JP Baillargeon","year":"2006","unstructured":"Baillargeon JP, Nestler JE. Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab. 2006;91:22\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"1057_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/me.2004-0178","volume":"19","author":"VL Nelson-Degrave","year":"2005","unstructured":"Nelson-Degrave VL, Wickenheisser JK, Hendricks KL, Asano T, Fujishiro M, Legro RS, et al. Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Mol Endocrinol. 2005;19:379\u201390.","journal-title":"Mol Endocrinol"},{"key":"1057_CR26","first-page":"2001","volume":"83","author":"JE Nestler","year":"1998","unstructured":"Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83:2001\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"1057_CR27","first-page":"302","volume":"81","author":"D Willis","year":"1996","unstructured":"Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab. 1996;81:302\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1057_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jsbmb.2009.12.010","volume":"122","author":"CG Baptiste","year":"2010","unstructured":"Baptiste CG, Battista MC, Trottier A, Baillargeon JP. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2010;122:42\u201352.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1057_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3389\/fendo.2019.00509","volume":"10","author":"G Vila","year":"2019","unstructured":"Vila G, J\u00f8rgensen JOL, Luger A, Stalla GK. Insulin resistance in patients with acromegaly. Front Endocrinol (Lausanne). 2019;10:509.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1057_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian Hyperandrogenism revisited. Endocr Rev. 2016;37:467\u2013520.","journal-title":"Endocr Rev"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01057-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-023-01057-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01057-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T05:14:14Z","timestamp":1675228454000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-023-01057-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1057"],"URL":"https:\/\/doi.org\/10.1186\/s12958-023-01057-x","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of Pittsburgh and Partners HealthCare institutional review boards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/a.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declare(s) that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}